| Serial Number | 77783471 |
| Word Mark | GLENERIC |
| Filing Date | Friday, July 17, 2009 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 14, 2012 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 17, 2010 |
| Goods and Services | Pharmaceuticals and Medicinal preparations, namely, opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 21, 2009 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Glenmark Pharmaceuticals Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mumbai 400026 IN |
| Party Name | Glenmark Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Mumbai 400026 IN |
| Event Date | Event Description |
| Monday, May 14, 2012 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, May 14, 2012 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, October 15, 2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 14, 2011 | EXTENSION 2 GRANTED |
| Wednesday, October 12, 2011 | EXTENSION 2 FILED |
| Thursday, October 13, 2011 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, October 12, 2011 | TEAS EXTENSION RECEIVED |
| Wednesday, March 9, 2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 7, 2011 | EXTENSION 1 GRANTED |
| Monday, March 7, 2011 | EXTENSION 1 FILED |
| Monday, March 7, 2011 | TEAS EXTENSION RECEIVED |
| Tuesday, October 12, 2010 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 17, 2010 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 17, 2010 | PUBLISHED FOR OPPOSITION |
| Friday, July 9, 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, July 8, 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 9, 2010 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, June 9, 2010 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 9, 2010 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 9, 2010 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, June 5, 2010 | DATA MODIFICATION COMPLETED |
| Thursday, June 3, 2010 | ASSIGNED TO LIE |
| Thursday, May 27, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 27, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 27, 2010 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, April 27, 2010 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, April 27, 2010 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, April 27, 2010 | SUSPENSION LETTER WRITTEN |
| Wednesday, April 14, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 14, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 14, 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 20, 2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 20, 2009 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 20, 2009 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 20, 2009 | ASSIGNED TO EXAMINER |
| Wednesday, July 22, 2009 | NOTICE OF PSEUDO MARK MAILED |
| Tuesday, July 21, 2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, July 21, 2009 | NEW APPLICATION ENTERED IN TRAM |